BioCryst Pharmaceuticals
Price & Volume
Stats
See more52W Range | $6.23-$11.22 |
Market Cap | $2.1B |
Shares Short | 27M |
Financials
See moreRevenue (12 Mos) | $940.6M |
Revenue Growth (YoY) | 33.6% |
Gross Profit (12 Mos) | $727.9M |
Diluted EPS | -$1.40 |
News
See moreYahoo Finance • 20 days ago
Is BioCryst’s (BCRX) Newest Approval Bigger Than It Looks?
Yahoo Finance • 25 days ago
4 Biotech Stocks to Watch as Potential Takeover Targets
Yahoo Finance • 26 days ago
BioCryst (BCRX) Turns its First Profit and Now Wants to Go Shopping for Rare Disease Drugs
Yahoo Finance • last month
Billionaire Portfolios: 2 Under-$20 Healthcare Stock Picks
About
CEO | Mr. Charles K. Gayer |
CFO | Mr. Babar Ghias |
Address | 4505 Emperor Boulevard, Durham, NC, United States, 27703 |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
Full-Time Employees | 435 |